These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12675283)

  • 1. Role of bradykinin in renoprotective effects by angiotensin II type 1 receptor antagonist in salt-sensitive hypertension.
    Yokota K; Kishida M; Ogura T; Suzuki J; Otsuka F; Mimura Y; Takeda M; Nakamura Y; Makino H
    Hypertens Res; 2003 Mar; 26(3):265-72. PubMed ID: 12675283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
    Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
    Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats.
    Yao K; Sato H; Ina Y; Suzuki K; Ohno T; Shirakura S
    Hypertens Res; 2003 Aug; 26(8):635-41. PubMed ID: 14567503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
    Otsuka F; Ogura T; Yamauchi T; Sato M; Kataoka H; Kageyama J; Makino H
    Kidney Blood Press Res; 2000; 23(1):35-41. PubMed ID: 10567852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event.
    Hirawa N; Uehara Y; Suzuki T; Kawabata Y; Numabe A; Gomi T; lkeda T; Kizuki K; Omata M
    Nephron; 1999 Feb; 81(2):183-93. PubMed ID: 9933754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.
    Harrison-Bernard LM; Schulman IH; Raij L
    Hypertension; 2003 Dec; 42(6):1157-63. PubMed ID: 14610098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Liang B; Leenen FH
    J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
    Hornig B; Kohler C; Schlink D; Tatge H; Drexler H
    Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension.
    Maitland K; Bridges L; Davis WP; Loscalzo J; Pointer MA
    Circulation; 2006 Aug; 114(9):905-11. PubMed ID: 16923758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade.
    Vanecková I; Kopkan L; Husková Z; Vanourková Z; Schejbalová S; Cervenka L; Kramer HJ
    Kidney Blood Press Res; 2007; 30(1):38-44. PubMed ID: 17237618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Fructose-Induced Hypertension and Renal Damage Are Exaggerated in Dahl Salt-Sensitive Rats via Renal Renin-Angiotensin System Activation.
    Xu L; Hu G; Qiu J; Fan Y; Ma Y; Miura T; Kohzuki M; Ito O
    J Am Heart Assoc; 2021 Jul; 10(14):e016543. PubMed ID: 34259014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benidipine and candesartan on kidney and vascular function in hypertensive Dahl rats.
    Yao K; Sato H; Sonoda R; Ina Y; Suzuki K; Ohno T
    Hypertens Res; 2003 Jul; 26(7):569-76. PubMed ID: 12924625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
    Leenen FH; Yuan B
    Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
    Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N
    Hypertens Res; 2008 Apr; 31(4):745-55. PubMed ID: 18633187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.